Art

J-GLOBAL ID：202102271433507755   Reference number：21A0348809

Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer

分泌PD-L1変異体は非小細胞肺癌におけるPD-L1遮断療法に対する耐性を仲介する【JST・京大機械翻訳】

Author (20)： Gong Bo (Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan) ,  Gong Bo (Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan) ,  Kiyotani Kazuma (Immunopharmacogenomics Group, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan) ,  Sakata Seiji (Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan) ,  Nagano Seiji (Laboratory of Immunology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan) ,  Nagano Seiji (Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan) ,  Kumehara Shun (Laboratory of Immunology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan) ,  Kumehara Shun (Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan) ,  Baba Satoko (Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan) ,  Besse Benjamin (INSERM U981, Gustave Roussy Cancer Campus, Universite Paris Saclay, Villejuif, France) ,  Besse Benjamin (Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France) ,  Yanagitani Noriko (The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan) ,  Friboulet Luc (INSERM U981, Gustave Roussy Cancer Campus, Universite Paris Saclay, Villejuif, France) ,  Nishio Makoto (The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan) ,  Takeuchi Kengo (Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan) ,  Takeuchi Kengo (Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan) ,  Kawamoto Hiroshi (Laboratory of Immunology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan) ,  Fujita Naoya (Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan) ,  Fujita Naoya (Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan) ,  Katayama Ryohei (Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan)
Material： Journal of Experimental Medicine  (J Exp Med)
Volume： 216  Issue： 4  Page： 982-1000  Publication year： 2019 
JST Material Number： A0937B  ISSN： 0022-1007  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Abstract/Point： Immune checkpoint blockade aga...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0348809&from=J-GLOBAL&jstjournalNo=A0937B") }}

Thesaurus term： gene ,  antibody ,  tumor ,  tumor cell ,  wild type ,  *non-small cell lung cancer ,  CD8 antigen ,  coculture
Semi thesaurus term： プログラム細胞死 ,  耐性機構 ,  治療抵抗性 ,  スプライスバリアント ,  *CD274抗原 ,  異種移植片 ,  HLA適合性 , 【Automatic Indexing@JST】

JST classification (1)： Immunotherapy for tumors  (GE03035B)

Reference (42)：

• Arnold. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc. Natl. Acad. Sci. USA. 2013, 110, E736. doi:10.1073/pnas.1222809110
• Callahan. Targeting T Cell Co-receptors for Cancer Therapy. Immunity. 2016, 44, 1069. doi:10.1016/j.immuni.2016.04.023
• Chen. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature. 2018, 560, 382. doi:10.1038/s41586-018-0392-8
• Crabtree. NFAT signaling: choreographing the social lives of cells. Cell. 2002, 109, 2, S67. doi:10.1016/S0092-8674(02)00699-2
• Dobin. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013, 29, 15. doi:10.1093/bioinformatics/bts635

Terms in the title (8)： 分泌 ,  PD-L1 ,  変異体 ,  非小細胞肺癌 ,  遮断 ,  療法 ,  耐性 ,  仲介